Quantcast

Sensus Healthcare Announces its Exhibitor Participation at the 86th National Congress of SIDeMaST in Verona, Italy

May 24, 2011

BOCA RATON, Fla., May 24, 2011 /PRNewswire/ – Sensus Healthcare is pleased to have exhibited at the 86th National Congress of SIDeMaST (The Italian Society of Dermatology) in Verona, Italy, May 18th – May 21st. Sensus Healthcare featured its SRT-100(TM) non-surgical, superficial photon therapy system for non-melanoma skin cancers. This year’s event was considered an important national event, representative of the Italian dermatology community. The conference provided 25 courses with CME (Continuing Medical Education), sessions with graduate pro-diagnosed cases, a course for nurses, various symposia of affiliated companies, and sessions devoted to clinical cases and open communications. In total there were approximately 227 readings preordained, 87 communications and 121 posters. The abstracts will be published in print as well as available online in a supplement to the Italian Journal of Dermatology.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO )

Featured in the abstracts is a piece titled, “Back to the Future with Photon Superficial Radiation Therapy for Non-Melanoma Skin Cancer,” written by Domenico Valente, MD, FAAD, Armand B. Cognetta, Jr., MD, and Angela M. Abbatecola, BS, MD, PhD. (Sensus Healthcare Medical Advisory Board Members).

“This conference demonstrated that the challenges that Dermatologists face are similar throughout the world and that the SRT-100(TM) can provide many solutions to those challenges. It’s clear that surgery is not the exclusive answer to treating skin cancers. Photon X-Ray treatment is a great & effective alternative.” — Joe Sardano, CEO of Sensus Healthcare

About Sensus Healthcare:

Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100(TM) systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions(TM), through our physician SRT-100(TM) users for their patients.

Contact:
Vicky Perez
Public Relations
561-922-5808 Ext 108
vicky@sensushealthcare.com

SOURCE Sensus Healthcare


Source: newswire



comments powered by Disqus